Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Topscience is a China-based life science research tools and drug discovery services company focused on serving researchers rather than developing its own clinical therapeutics. The company provides compound libraries, screening compounds, inhibitors and agonists, recombinant proteins, antibodies, peptides, and custom synthesis and pharmacology support for early-stage research. Its website also highlights AI-assisted drug discovery, target discovery and validation, molecular docking and virtual screening, lead optimization, and compound activity screening capabilities. Topscience appears to operate as a private, active company with core operations in Shanghai and additional logistics or operating presence in Boston and the Netherlands. Based on available public information, it is best characterized as a preclinical-enabling research platform and supplier to the biotech and pharmaceutical R&D ecosystem rather than a clinical-stage biotech developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shanghai Topscience.